Abstract
Tiered immunotoxicity testing strategies have been developed in both rats and mice. These tiered systems focus on the detection of compound-induced immunosuppression. Clinical relevance has clearly been demonstrated in the case of pharmaceuticals for which the primary aim is to induce immunosuppression in organ transplant recipients. Validation for pharmaceuticals is still ongoing.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
